Catch up on this week's highlights in retina.
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010
PHOTON Trial Outcomes: Impact on DME Patient Care in Clinical Practice
Researchers examine brain immune cell impact on the eye
Implementing Higher Molar Dose in Your Clinical Practice
European Commission approves aflibercept biosimilar Mynzepli
Study establishes reference data set for geographic atrophy lesion progression